C/EBPβ 调节HIF-1α驱动的入侵非小细胞肺癌细胞
Seung Hee Seo1, Ji Hae Lee1, Eun Kyung Choi1
1Cancer Metastasis Branch, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.
Biomolecules
|January 25, 2025
概括
CCAAT/增强剂结合蛋白β (C/EBPβ) 通过调节缺氧诱导因子1-alpha (HIF1A) 来驱动非小细胞肺癌 (NSCLC) 转移. 准C/EBPβ-HIF1A-GLUT1通路可以防止NSCLC的传播.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 转移性癌症是癌症死亡的主要原因,需要确定有效治疗的分子点.
- 瘤缺氧是一种常见的特征,促进癌症的进展,治疗耐药性和转移.
- 了解驱动转移的分子机制对于开发向疗法至关重要.
研究的目的:
- 研究CCAAT/增强剂结合蛋白β (C/EBPβ) 在调节缺氧诱导因子1亚单元α (HIF1A) 中的作用及其对非小细胞肺癌 (NSCLC) 细胞在缺氧条件下的迁移和入侵的影响.
- 为了阐明涉及C/EBPβ,HIF1A和GLUT1在NSCLC转移中的分子途径.
主要方法:
- 在NSCLC细胞中通过C/EBPβ研究HIF1A的转录调节,使用敲击和过度表达技术.
- 进行了染色体免疫沉试验,以确认C/EBPβ与HIF1A促进体的直接结合.
- 在低氧条件下评估了C/EBPβ,HIF1A和SLC2A1 (GLUT1) 对NSCLC细胞迁移和入侵的功能影响.
主要成果:
- C/EBPβ直接调节HIF1A转录,其表达水平与NSCLC细胞中的HIF-1α表达相关.
- 过度表达C/EBPβ增强了NSCLC细胞迁移和在低氧状态下的入侵,这种影响取决于HIF1A.
- 沉默HIF1A或其向基因SLC2A1 (编码GLUT1) 取消了C/EBPβ诱导的细胞迁移和侵入的增加.
结论:
- 在低氧瘤微环境中,C/EBPβ充当NSCLC细胞入侵的关键调节者.
- C/EBPβ-HIF-1α-GLUT1轴被确定为促进NSCLC转移的关键途径.
- 这一途径代表了抑制NSCLC进展和改善患者结果的潜在治疗标.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Cell Specific Gene Expression
13.4K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.4K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Hedgehog Signaling Pathway
7.3K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.3K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K


